Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from cyclosporine to tacrolimus with randomized C0 versus Bayesian C4 monitoring in stable liver transplant recipients
NL-OMON22214Not yet recruiting
- Sponsor
- MD. PhD. B. van Hoek
- Start
- Sep 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of tacrolimus and cyclosporine in chronic kidney disease (CKD) and liver transplant (2 arms), sponsored by MD. PhD. B. van Hoek. Primary endpoint: Creatinine clearance change. Planned start Sep 2008; status: not yet recruiting.
02
Drugs
tacrolimuscyclosporine
03
Conditions
chronic kidney disease (CKD)liver transplant
Beyond the preview
Go deeper on NL-OMON22214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22214.